Dry Eye Startup Practice
Dry Eye Startup Practice
Starting a dry eye service does not require a full diagnostic lab. What it requires is rapid identification of dry eye subtypes, objective visualization, and efficient patient communication. The QuikVue + MeiboVue screening pack is designed precisely for this purpose. | ||
Comprehensive Front-Line Screening: Tear Film, Eyelids, and Meibomian Glands Most dry eye cases involve either tear film instability or meibomian gland dysfunction (MGD)—often both.
Together, they allow the practice to:
This eliminates reliance on subjective symptom questionnaires alone and enables clinically defensible screening within minutes. | ||
Minimal Learning Curve, Immediate Clinical Deployment For startup practices, time to adoption matters more than feature depth.
This means:
| ||
| Strong Patient Education and Conversion Capability Dry eye treatment acceptance depends on whether patients understand their condition.
For practices planning to introduce:
The screening pack becomes the conversion engine, not just a diagnostic tool. | |
Low Capital Investment, Fast ROI Compared to advanced diagnostic platforms, the screening pack:
This allows practices to:
| ||
![]() | Future-Proof and Upgrade-Friendly The screening pack does not lock the practice into a dead-end system.
Practices can start small, then expand with confidence. | |
Summary: Designed for Speed, Clarity, and Growth The QuikVue + MeiboVue Dry Eye Screening Pack enables practices to:
For startup or early-stage practices, it is not a compromise solution—it is a strategic starting point. | ||